Therapeutic effects of radix dipsaci, pyrola herb, and cynomorium songaricum on bone metabolism of ovariectomized rats

Liu, Meijie; Xiao, Gary Guishan; Rong, Peijing; Zhang, Zhiguo; Dong, Jiazi; Zhao, Hongyan; Li, Honghong; Li, Yan; Pan, Jinghua; Liu, Hong; Wang, Wenlai; Zha, Qinglin; Ju, Dianwen

doi:10.1186/1472-6882-12-67

Cited by 22 publications

(20 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…the exact mechanism underlying is still unknown. Our previous study and others showed that Radix Dipsaci decoction and Pyrola Herb decoction enhanced significantly bone formation in OVX rats [8,14]. Our results in this study showed that Chinese herbs SACD and RCD increased bone formation by stimulating OPG expression and downregulating RANKL expression in OB and bMSC.…”

Section: Discussionsupporting

confidence: 65%

“…However, the anti-osteoporotic mechanisms are still unknown. Our previous studies suggest that Chinese herbs increased bone formation by stimulating OPG expression and downregulating RANKL in bone marrow cells [8]. The anti-osteoporotic effects are selective for these herbs.…”

Section: Introductionmentioning

confidence: 99%

“…The anti-osteoporotic effects are selective for these herbs. For example, among herb medicines studied in the previous study, only Radix Dipsaci and Pyrola Herb had significant anti-osteoporotic effects [8]. To develop the most effective herb medicine as an alternative treatment for osteoporosis, in this study we selected additional four herbs, Semen Astragali Complanati , Rhizoma Cibotii , Herba Cistanches , and Semen Allii Tuberosi , from 24 Chinese herbs available in Chinese clinics.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Semen astragali complanati- and rhizoma cibotii-enhanced bone formation in osteoporosis rats

Liu

Xiao

Rong

et al. 2013

BMC Complement Altern Med

Self Cite

View full text Add to dashboard Cite

BackgroundGrowing evidence shows that herb medicines have some anti-osteoporotic effects, the mechanism underlying is unknown. This study aims to investigate the therapeutic effect of Chinese herb supplements on rats that had osteoporosis-like symptom induced by ovariectomy (OVX).MethodsOVX or sham operations were performed on virgin Wistar rats at three-month old, which were randomly divided into eight groups: sham (sham); OVX control group (OVX); OVX rats with treatments [either diethylstilbestrol (DES) or Semen Astragali Complanati decoction (SACD) or Rhizoma Cibotii decoction (RCD) or Herba Cistanches decoction (HCD) or Semen Allii Tuberosi decoction (SATD)]. Non-surgical rats were served as a normal control (NC). The treatments began 4 weeks after surgery, and lasted for 12 weeks. Bone mass and its turnover were analyzed by histomorphometry. Levels of protein and mRNA of osteoprotegerin (OPG) and receptor activator of nuclear factor κB ligand (RANKL) in osteoblasts (OB) and bone marrow stromal cells (bMSC) were evaluated by immunohistochemistry and in situ hybridization.ResultsCompared to OVX control, TBV% in both SACD and RCD groups was increased significantly, while TRS%, TFS%, MAR, and mAR were decreased remarkably in the SACD group, only TRS% decreased dramatically in the RCD group. No significant changes in bone formation were observed in either HCD or SATD groups. OPG levels in both protein and mRNA were reduced consistantly in OB and bMSC from OVX control rats, in contrast, RANKL levels in both protein and mRNA were increased significantly. These effects were substantially reversed by treatments with either DES or SACD or RCD. No significant changes in both OPG and RANKL expression were observed in OB and bMSC from OVX rats treated with SATD and HCD.ConclusionsOur study showed that SACD and RCD increased bone formation by stimulating OPG expression and downregulating RANKL expression in OB and bMSC. This suggests that SACD and RCD may be developed as alternative anti-osteoporotic agents for therapy of postmenopausal osteoporosis.

show abstract

Section: Discussionsupporting

confidence: 65%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Semen astragali complanati- and rhizoma cibotii-enhanced bone formation in osteoporosis rats

Liu

Xiao

Rong

et al. 2013

BMC Complement Altern Med

Self Cite

View full text Add to dashboard Cite

show abstract

“…Our results found that most CHM coprescribed with AIs was used for arthritis and pain relief. For example, du-huo-ji-sheng-tang and xu-duan ( Dipsaci radix ) are used to treat osteoarthritis, osteoporosis, and other bone diseases 38–41. Shao-yao-gan-cao-tang is used to relieve dysmenorrhea and muscle pain 42…”

Section: Discussionmentioning

confidence: 99%

Coprescription of Chinese herbal medicine and Western medication among female patients with breast cancer in Taiwan: analysis of national insurance claims

Wang¹,

Chang²,

Chen³

et al. 2014

PPA

View full text Add to dashboard Cite

BackgroundMany female breast cancer (FBC) patients take Chinese herbal medicine (CHM) and Western medication (WM) concurrently in Taiwan. Despite the possibility of interactions between the CHM and WM mentioned in previous studies, the pattern of these coprescriptions in FBC patients remains unclear. Hence, the aim of the present study is to investigate the utilization of coprescriptions of CHM and WM among the FBC patients in Taiwan.MethodsThe study was a cross-sectional survey using the sampled cohort in 2009 obtained from the National Health Insurance Research Database in Taiwan. There were 3,507 FBC patients identified from the registry for catastrophic illness patients. Ambulatory visit records, corresponding prescriptions, and the data of beneficiaries belonging to the FBC patients were further extracted. A total of 1,086 FBC patients used CHM at least once. CHM and WM prescribed within any overlapping duration were defined as coprescriptions.ResultsThere were 868 (80.0%) patients simultaneously receiving CHM and WM. A total of 4,927 CHM prescriptions and 6,358 WM prescriptions were prescribed concurrently. Among these coprescriptions, the most frequently used CHM was jia-wei-xiao-yao-san (21.2%), and the most frequently coprescribed WM was acetaminophen (38.9%), followed by tamoxifen (25.5%). There were 346 patients using systemic adjuvant therapy and CHM concurrently. The most commonly coprescribed CHM with chemotherapy, endocrine therapy, and trastuzumab was xiang-sha-liu-jun-zi-tang, jia-wei-xiao-yao-san, and zhi-gan-cao-tang, respectively.ConclusionThe combined use of CHM with WM is prevalent. The main purpose of combining CHM with systemic cancer treatment is to alleviate the treatment-related adverse effects. However, the combination may result in the potential risk of drug–herb interactions. Further clinical studies are needed to evaluate the efficacy and safety of the CHM and WM coprescriptions for FBC patients.

show abstract

“…Following multiple washes in 4X SSC at room temperature, the slides were incubated at 37˚C in a blocking reagent for 30 min, a biotinylated anti-digoxin antibody for 60 min, SABC for 20 min and the biotinylated peroxydase for 20 min, at 37˚C, followed by staining with DAB (Sigma, St. Louis, MO, USA). Sections were then covered with glycerol-gelatin and coverslips for microscopic examination (11,12). The SATB1 probe (sequence: 5'-TCTTTAATTTCTAATATATTTAGAA-3') was synthesized and labeled with biotin at the 5' end by Sangon Bioengineering Technology and Services Co., Ltd. (Shanghai, China).…”

Section: Methodsmentioning

confidence: 99%

Correlation between SATB1 and Bcl-2 expression in human glioblastoma multiforme

Chu

Feng

et al. 2012

Molecular Medicine Reports

View full text Add to dashboard Cite

Special AT-rich sequence-binding protein-1 (SATB1) has been reported to be overexpressed in numerous human tumors. The aim of the present study was to determine the correlation and clinical significance between the expression of SATB1 and B-cell lymphoma 2 (Bcl-2) in human glioblastoma multiforme (GBM). Samples from 70 patients with GBMs were analyzed and 10 normal brain tissues were used as the control group. In situ hybridization was used to detect SATB1 mRNA expression and immunohistochemistry was used to detect Bcl-2 and proliferating cell nuclear antigen (PCNA) protein expression. Apoptosis was detected with flow cytometry. The SATB1 mRNA and Bcl-2 protein levels were found to be significantly higher in GBM tissues than in normal brain and their levels were associated with patient survival, but not associated with patient gender, age and tumor size and site. A positive correlation was observed between SATB1 mRNA and Bcl-2 protein and between SATB1 mRNA and PCNA. A negative correlation was observed between SATB1 mRNA and apoptosis and between Bcl-2 and apoptosis. A positive correlation existed between Bcl-2 and PCNA. Patients with GBM identified as SATB1 mRNA (+) and Bcl-2 (+) were associated with a poor prognosis. Therefore, assessment of SATB1 and Bcl-2 co-expression may provide important information for the diagnosis, therapy and prognosis of GBM.

show abstract

Therapeutic effects of radix dipsaci, pyrola herb, and cynomorium songaricum on bone metabolism of ovariectomized rats

Cited by 22 publications

References 15 publications

Semen astragali complanati- and rhizoma cibotii-enhanced bone formation in osteoporosis rats

Semen astragali complanati- and rhizoma cibotii-enhanced bone formation in osteoporosis rats

Coprescription of Chinese herbal medicine and Western medication among female patients with breast cancer in Taiwan: analysis of national insurance claims

Correlation between SATB1 and Bcl-2 expression in human glioblastoma multiforme

Contact Info

Product

Resources

About